What links vascular calcifications to osteoporotic fractures?

2
Joint Bone Spine 77 (2010) 519–520 Research lectures What links vascular calcifications to osteoporotic fractures? Pawel Szulc Unité Inserm 831, université de Lyon, hôpital Édouard-Herriot, Pavillon F, place d’Arsonval, 69437 Lyon, France article info Article history: Accepted 22 July 2010 Available online 20 October 2010 Epidemiological studies have documented an association between osteoporosis and cardiovascular disease in both males and females [1]. In these studies, individuals with severe cardiovascular disease were at increased risk for osteoporosis and vice versa. 1. Osteoporosis risk in patients with cardiovascular disease In large epidemiological studies, heart failure was associated with a higher risk of hip fracture [2,5]. The risk of hip fracture was also elevated in patients with coronary artery disease, hyperten- sion, or peripheral occlusive arterial disease [3,6]. The fracture risk increased with the severity of the cardiovascular disease. The haz- ard ratio of hip fracture was 4.4 in patients with heart failure and 2.3 in those with coronary artery disease [3]. The relative risk of hip fracture was increased 2-fold in patients with one hospitaliza- tion for cardiovascular disease and 6-fold in patients with six or more admissions for cardiovascular disease, compared to patients never admitted for cardiovascular disease [4]. These results may be ascribable in part to the lower areal bone mineral density (aBMD) values seen in patients with cardiovascular disease [7,8]. 2. Cardiovascular risk in patients with osteoporosis The cardiovascular risk is increased in patients who have bone metabolism abnormalities (diminished aBMD, fast bone turnover, and/or vitamin D deficiency). Women with postmenopausal osteo- porosis may be at increased risk for severe cardiovascular events (myocardial infarction or stroke) [9]. In a prospective study, lower cortical bone area values were associated with an increased risk of coronary artery disease in females but not in males [10]. Patients with elevated bone resorption markers are at high risk for myocar- dial infarction and stroke [11,12]. A 10-year prospective study found that males with low 25-hydroxy vitamin D levels were at increased risk for myocardial infarction [13]. These data from E-mail address: [email protected]. prospective studies establish that cardiovascular disease is asso- ciated with a high risk of fracture and that bone metabolism abnormalities are associated with a high risk of cardiovascular events. Two clinical situations deserve special attention. 3. Stroke and osteoporotic fractures In prospective studies, low aBMD values and rapid bone resorp- tion were associated with an elevated risk of stroke [9,11,14]. Stroke leads to decreased mobility and to bone nerve supply alterations that cause accelerated bone loss, most notably on the paralyzed side. In addition, stroke patients have higher risk of fall. These fac- tors combine to substantially increase in the fracture risk after a stroke, particularly within the first year [3,15]. Therefore, the bone status of stroke patients should be evaluated in depth and antire- sorption medications given if appropriate. 4. Aortic calcifications and osteoporosis Several studies found an increased risk of osteoporosis in patients with aortic calcifications. Postmenopausal women with abdominal aortic calcifications had lower volumetric BMD (vBMD) values at the lumbar spine and higher prevalences of vertebral and hip fractures compared to controls [16]. In postmenopausal out- patients evaluated for osteoporosis, aortic calcifications were also associated with higher prevalence of vertebral and hip fractures [17]. In a prospective study of postmenopausal women, extensive aortic calcifications were associated with low hip and lumbar spine BMD values, accelerated bone loss at the hip, and an increased risk of hip fractures [18]. Similar results were obtained in cohorts that included men and women or only men. In a cohort of elderly men and women, the extent of aortic calcifications was negatively associated with trabecular bone vBMD at the lumbar spine [19]. Extensive aortic calcifications were associated with an increased prevalence of vertebral fractures [20]. In a cohort of elderly men followed up for 10 years in the MINOS study, extensive aortic cal- cifications were associated with an elevated risk of osteoporotic 1297-319X/$ – see front matter © 2010 Société franc ¸ aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved. doi:10.1016/j.jbspin.2010.09.003

Transcript of What links vascular calcifications to osteoporotic fractures?

Page 1: What links vascular calcifications to osteoporotic fractures?

R

W

PU

a

AAA

bfd

1

wasia2htmnav

2

map(ccwdfa

1d

Joint Bone Spine 77 (2010) 519–520

esearch lectures

hat links vascular calcifications to osteoporotic fractures?

awel Szulcnité Inserm 831, université de Lyon, hôpital Édouard-Herriot, Pavillon F, place d’Arsonval, 69437 Lyon, France

r t i c l e i n f o

rticle history:ccepted 22 July 2010

vailable online 20 October 2010

Epidemiological studies have documented an associationetween osteoporosis and cardiovascular disease in both males andemales [1]. In these studies, individuals with severe cardiovascularisease were at increased risk for osteoporosis and vice versa.

. Osteoporosis risk in patients with cardiovascular disease

In large epidemiological studies, heart failure was associatedith a higher risk of hip fracture [2,5]. The risk of hip fracture was

lso elevated in patients with coronary artery disease, hyperten-ion, or peripheral occlusive arterial disease [3,6]. The fracture riskncreased with the severity of the cardiovascular disease. The haz-rd ratio of hip fracture was 4.4 in patients with heart failure and.3 in those with coronary artery disease [3]. The relative risk ofip fracture was increased 2-fold in patients with one hospitaliza-ion for cardiovascular disease and 6-fold in patients with six or

ore admissions for cardiovascular disease, compared to patientsever admitted for cardiovascular disease [4]. These results may bescribable in part to the lower areal bone mineral density (aBMD)alues seen in patients with cardiovascular disease [7,8].

. Cardiovascular risk in patients with osteoporosis

The cardiovascular risk is increased in patients who have boneetabolism abnormalities (diminished aBMD, fast bone turnover,

nd/or vitamin D deficiency). Women with postmenopausal osteo-orosis may be at increased risk for severe cardiovascular eventsmyocardial infarction or stroke) [9]. In a prospective study, lowerortical bone area values were associated with an increased risk oforonary artery disease in females but not in males [10]. Patients

ith elevated bone resorption markers are at high risk for myocar-ial infarction and stroke [11,12]. A 10-year prospective studyound that males with low 25-hydroxy vitamin D levels weret increased risk for myocardial infarction [13]. These data from

E-mail address: [email protected].

297-319X/$ – see front matter © 2010 Société francaise de rhumatologie. Published by Eoi:10.1016/j.jbspin.2010.09.003

prospective studies establish that cardiovascular disease is asso-ciated with a high risk of fracture and that bone metabolismabnormalities are associated with a high risk of cardiovascularevents. Two clinical situations deserve special attention.

3. Stroke and osteoporotic fractures

In prospective studies, low aBMD values and rapid bone resorp-tion were associated with an elevated risk of stroke [9,11,14]. Strokeleads to decreased mobility and to bone nerve supply alterationsthat cause accelerated bone loss, most notably on the paralyzedside. In addition, stroke patients have higher risk of fall. These fac-tors combine to substantially increase in the fracture risk after astroke, particularly within the first year [3,15]. Therefore, the bonestatus of stroke patients should be evaluated in depth and antire-sorption medications given if appropriate.

4. Aortic calcifications and osteoporosis

Several studies found an increased risk of osteoporosis inpatients with aortic calcifications. Postmenopausal women withabdominal aortic calcifications had lower volumetric BMD (vBMD)values at the lumbar spine and higher prevalences of vertebral andhip fractures compared to controls [16]. In postmenopausal out-patients evaluated for osteoporosis, aortic calcifications were alsoassociated with higher prevalence of vertebral and hip fractures[17]. In a prospective study of postmenopausal women, extensiveaortic calcifications were associated with low hip and lumbar spineBMD values, accelerated bone loss at the hip, and an increasedrisk of hip fractures [18]. Similar results were obtained in cohortsthat included men and women or only men. In a cohort of elderlymen and women, the extent of aortic calcifications was negatively

associated with trabecular bone vBMD at the lumbar spine [19].Extensive aortic calcifications were associated with an increasedprevalence of vertebral fractures [20]. In a cohort of elderly menfollowed up for 10 years in the MINOS study, extensive aortic cal-cifications were associated with an elevated risk of osteoporotic

lsevier Masson SAS. All rights reserved.

Page 2: What links vascular calcifications to osteoporotic fractures?

5 Spine

feDbm

5m

mcitohbaaficidalt

mpaifat

C

R

[

[

[

[

[

[

[

[

[

[

[

[

[

20 P. Szulc / Joint Bone

ractures [21]. Among older men in the Strambo study, those havingxtensive aortic calcifications detected using VFA software (Hologiciscovery A) were more likely to have moderate or severe verte-ral fractures (according to the Genant’s semiquantitative score foren) and multiple vertebral fractures [22–24].

. Methodological limitations of available studies – possibleechanisms

The data reviewed above were obtained using multivariateodels adjusted for confounders (age, body weight, life style,

o-morbidities, and treatments). However, these confounders var-ed across studies, complicating the identification of mechanismshat might link osteoporosis and cardiovascular disease. A numberf risk factors predispose to both conditions, including smoking,ypertension, and diabetes. The effects of cardiovascular drugs onone metabolism may be favourable (statins, thiazide diuretics,nd spironolactone) or unfavourable (furosemide and vitamin Kntagonists). The association between cardiovascular disease andracture risk is not fully explained by the lower aBMD values seenn cardiovascular patients. Muscle mass may be lost as a result ofhronic disease, diminished physical activity, and immobility dur-ng repeated hospitalizations. Cardiovascular patients may haveisturbances in cerebral blood flow related to the disease (e.g.rrhythmia) or drugs (e.g. orthostatic hypotension). Both muscleoss and altered cerebral blood flow may cause balance disorders,hereby increasing the risk of falls.

The links between cardiovascular disease and osteoporosis haveajor practical relevance. Many patients seen in everyday clinical

ractice have severe cardiovascular disease (heart failure, stroke,nd/or extensive aortic calcifications). These patients, who are eas-ly identified, should be viewed as having a high risk of osteoporoticractures that requires an in-depth bone status assessment. Thispproach may diminish osteoporosis-related morbidity and mor-ality rates while limiting healthcare costs.

onflict of interest statement

The author declares no conflict of interest.

eferences

[1] Tremollieres F, Ribot C. Bone mineral density and prediction of nonosteoporoticdisease. Maturitas 2010;65:348–51.

[2] Carbone L, Buzková P, Fink HA, et al. Hip fractures and heart failure: findingsfrom the Cardiovascular Health Study. Eur Heart J 2010;31:77–84.

[

[

77 (2010) 519–520

[3] Sennerby U, Melhus H, Gedeborg R, et al. Cardiovascular diseases and risk ofhip fracture. JAMA 2009;302:1666–73.

[4] Sennerby U, Farahmand B, Ahlbom A, et al. Cardiovascular diseases and futurerisk of hip fracture in women. Osteoporos Int 2007;18:1355–62.

[5] van Diepen S, Majumdar SR, Bakal JA, et al. Heart failure is a risk factor fororthopedic fracture: a population-based analysis of 16,294 patients. Circulation2008;118:1946–52.

[6] Vestergaard P, Rejnmark L, Mosekilde L. Hypertension is a risk factor for frac-tures. Calcif Tissue Int 2009;84:103–11.

[7] Farhat GN, Strotmeyer ES, Newman AB, et al. Volumetric and areal bone min-eral density measures are associated with cardiovascular disease in older menand women: the health, aging, and body composition study. Calcif Tissue Int2006;79:102–11.

[8] Jørgensen L, Joakimsen O, Rosvold Berntsen GK, et al. Low bone mineral densityis related to echogenic carotid artery plaques: a population-based study. Am JEpidemiol 2004;160:549–56.

[9] Tankó LB, Christiansen C, Cox DA, et al. Relationship between osteoporo-sis and cardiovascular disease in postmenopausal women. J Bone Miner Res2005;20:1912–20.

10] Samelson EJ, Kiel DP, Broe KE, et al. Metacarpal cortical area and risk of coro-nary heart disease: the Framingham Study. Am J Epidemiol 2004;159:589–95.

11] Szulc P, Samelson EJ, Kiel DP, et al. Increased bone resorption is associated withincreased risk of cardiovascular events in men: the MINOS study. J Bone MinerRes 2009;24:2023–31.

12] Kitahara T, Takeishi Y, Arimoto T, et al. Serum carboxy-terminal telopeptide oftype I collagen (ICTP) predicts cardiac events in chronic heart failure patientswith preserved left ventricular systolic function. Circ J 2007;71:929–35.

13] Giovannucci E, Liu Y, Hollis BW, et al. 25-hydroxyvitamin D and riskof myocardial infarction in men: a prospective study. Arch Intern Med2008;168:1174–80.

14] Nordström A, Eriksson M, Stegmayr B, et al. Low bone mineral density isan independent risk factor for stroke and death. Cerebrovasc Dis 2010;29:130–6.

15] Pouwels S, Lalmohamed A, Leufkens B, et al. Risk of hip/femur fracture afterstroke: a population-based case-control study. Stroke 2009;40:3281–5.

16] Schulz E, Arfai K, Liu X, et al. Aortic calcification and the risk of osteoporosisand fractures. J Clin Endocrinol Metab 2004;89:4246–53.

17] Rajzbaum G, Roger VL, Bézie Y, et al. French women, fractures and aortic calci-fications. J Intern Med 2005;257:117–9.

18] Bagger YZ, Tankó LB, Alexandersen P, et al. Radiographic measure of aorta cal-cification is a site-specific predictor of bone loss and fracture risk at the hip. JIntern Med 2006;259:598–605.

19] Hyder JA, Allison MA, Wong N, et al. Association of coronary artery and aorticcalcium with lumbar bone density: the MESA Abdominal Aortic Calcium Study.Am J Epidemiol 2009;169:186–94.

20] Naves M, Rodríguez-García M, Díaz-López JB, et al. Progression of vascular cal-cifications is associated with greater bone loss and increased bone fractures.Osteoporos Int 2008;19:1161–6.

21] Szulc P, Kiel DP, Delmas PD. Calcifications in the abdominal aorta predict frac-tures in men: MINOS study. J Bone Miner Res 2008;23:95–102.

22] Genant HK, Wu CY, van Kuijk C, et al. Vertebral fracture assessment using asemiquantitative technique. J Bone Miner Res 1993;8:1137–48.

23] Szulc P, Munoz F, Marchand F, et al. Semiquantitative evaluation of preva-lent vertebral deformities in men and their relationship with osteoporosis: theMINOS study. Osteoporos Int 2001;12:302–10.

24] Szulc P, Chapurlat R. Older men with extended aortic calcifications have morevertebral fractures – a cross-sectional study in the Strambo cohort using theHologic VFA software. J Clin Densitom 2010;13:109 [Abstract 003].